Ablation is associated with reduced risk of recurrent stroke for patients with artrial fibrillation.
Risk scores help identify high-risk patients who may benefit from intervention.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Patients taking apixaban showed significantly less intracranial hemorrhage (0.33% per year) vs patients taking warfarin (0.80% per year), no matter the type and location.
More than 80% of ischemic stroke patients weren't getting adequate anticoagulation therapy.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
It is not clear if identifying atrial fibrillation in an effort to prevent stroke would be an effective preventive strategy.
The increased risk of stroke was only observed among patients with diabetes controlled by insulin.
At 1 year, no difference in complications was observed between the 2 age groups.
Twelve months after AFib ablation, risk of recurrent stroke or AFib is low.
Only 46% of patients with indications received OACs at discharge from the hospital.
32.1% believed that heart attack is a major risk factor of AF, which is incorrect.
Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation, while insomnia was associated with a 29% increased risk.
Long episodes of AT/AF were more likely to be associated with clinical events than short episodes.
Patients with untreated OSA face an increased risk of complications.
Treating older patients with a vitamin K antagonist may be warranted since thrombosis risk is more markedly increased than bleeding risk with rising age.
Patients who were on the anticoagulant had an increase risk of dementia independent of atrial fibrillation.
The incidence of atrial fibrillation in stroke patients with an insertable cardiac monitor was higher than that reported previously.
The authors suggest that physicians may be concerned about bleeding risk.
A-fib was associated with central apnea, Cheyne Stokes respiration, apnea hypopnea index in older men.
Use of ATRIA may help reduce the risk of over-treating low-risk patients with anticoagulants.
Despite a higher risk of stroke, women are often prescribed the lower dose.
30 days after surgery, only 7% of those who received the botulinum toxin developed A-Fib compared to 30% given saline.
Primary care physicians are failing to provide information about stroke or bleeding risk.
Longer duration of AF was associated with greater risk of dementia.
Neurology Advisor Articles
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Deep Brain Stimulation Improves Survival in Parkinson Disease
- Diet Linked to Multiple Sclerosis Disability, Disease Severity
- FDA Approves Vercise Deep Brain Stimulation System for Parkinson Disease
- Obesity and Alzheimer Disease: Exploring Risk Modification
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- Language Deficits and EEG Changes Predict Conversion From MCI to Alzheimer Disease
- Sex Differences in Parkinson Disease: Implications for Diagnosis, Treatment
- Understanding Poststroke Depression: Risk Factors and Treatment
- Value-Based Payment Modifier Program Has Little Effect on Practice Performance
- Growth in Health Care Spending Slowed in 2016
- Paternal Selective Serotonin Reuptake Inhibitor Use Linked to ADHD in Offspring